Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, UT
Clinical Trial Details
Research Study Summary
Type II Diabetes- Patients currently taking Metformin
Type II diabetes accounts for more than 90% of the total number of diabetes cases. This disease is diagnosed by increased blood glucose (sugar) levels and the body’s inability to secrete adequate insulin to maintain normal blood glucose levels. As physicians, we understand the frustration some patients have with their diabetes. For this reason, our office has chosen to be part of a medical research study evaluating the safety and effectiveness of an investigational medication to see if it helps better control Type 2 diabetes than current medications.If it is determined that you are eligible for the study, you will be asked to come to our office every 4 to 6 weeks over a 3-year period. During these visits, various medical tests and evaluations will be performed to determine your safety and progress throughout the study. Qualified patients will receive study-related medical evaluations and study medication at no cost.
Individuals may be eligible to participate in the study if they:
- Are 18-75 years of age
- Have a confirmed diagnosis of type 2 diabetes
- Have not been successful using current medical regimen
Patient Exclusion Criteria: Hgb A1c- less than 7 or greater than 10 (will be determined at study visit)
To Learn more
Both Male and Female
Date Last Changed:
July 24, 2013
DISCLAIMER: CenterWatch does not conduct clinical research.
CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies,
contract research organizations, clinical research sites and other interested parties. This information
is designed to help patients find clinical trials of interest and contact the research centers
conducting the trials.